- April 26, 2022
- Newsletter
- 617-430-5616
Menu
» Home » CAD » Oncology » Orthopedic Oncology » Fibrosarcoma
ADVERTISEMENT
ADVERTISEMENT
» Home » CAD » Oncology » Orthopedic Oncology » Fibrosarcoma
Background
Fibrosarcomas are malignant tumours made of fibroblasts with variable collagen synthesis and a “herringbone” structure. Previously, the reported incidence was much higher because many non-mesenchymal and mesenchymal tumors which mimic fibrosarcomas were incorrectly diagnosed as fibrosarcoma.
In recent decades this has changed, so the incidence rate has been dropping steadily. There are two forms of fibrosarcomas: infantile or congenital fibrosarcomas, and adult-type fibrosarcomas. Adult-type fibrosarcomas are extremely malignant, whereas infantile fibrosarcomas rarely metastasise.
Epidemiology
Fibrosarcomas are more prevalent in middle-aged and elderly individuals, and they are extremely uncommon in youngsters. Males are slightly more likely to be affected. Some common sites which develop fibrosarcoma include deep soft tissues in the head, neck, trunk, and within the pelvic region.
In an analysis of adult fibrosarcomas, 80% were categorized within grades 2 and 3 (high-grade). Out of the lesions which were diagnosed as grade 1, 25% later progressed into high-grade sarcomas over time.
Anatomy
Pathophysiology
Fibrosarcoma can develop from mesenchymal cells and is formed of uncontrollably proliferating spindle-shaped fibroblasts. Most often, fibrosarcoma can arise in the tendons and fascia of deep tissues, although it can also arise in the medullary canal or periosteum of bones. Additionally, preexisting bone lesions or irradiated tissues may cause subsequent bone fibrosarcoma.
Etiology
Fibrosarcoma often arises from fascia and tendons of deep tissue, although they can also develop in the medullary canal or periosteum of bones as a primary or secondary tumor. Bone fibrosarcoma can be caused by bone injuries which occurred due to radiation therapy or physical trauma.
Genetics
Prognostic Factors
The 2-year survival rate for fibrosarcoma is below 70%, and the 5-year survival rate is below 55%.
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Future Trends
References
https://www.ncbi.nlm.nih.gov/books/NBK560759/
ADVERTISEMENT
» Home » CAD » Oncology » Orthopedic Oncology » Fibrosarcoma
Fibrosarcomas are malignant tumours made of fibroblasts with variable collagen synthesis and a “herringbone” structure. Previously, the reported incidence was much higher because many non-mesenchymal and mesenchymal tumors which mimic fibrosarcomas were incorrectly diagnosed as fibrosarcoma.
In recent decades this has changed, so the incidence rate has been dropping steadily. There are two forms of fibrosarcomas: infantile or congenital fibrosarcomas, and adult-type fibrosarcomas. Adult-type fibrosarcomas are extremely malignant, whereas infantile fibrosarcomas rarely metastasise.
Fibrosarcomas are more prevalent in middle-aged and elderly individuals, and they are extremely uncommon in youngsters. Males are slightly more likely to be affected. Some common sites which develop fibrosarcoma include deep soft tissues in the head, neck, trunk, and within the pelvic region.
In an analysis of adult fibrosarcomas, 80% were categorized within grades 2 and 3 (high-grade). Out of the lesions which were diagnosed as grade 1, 25% later progressed into high-grade sarcomas over time.
Fibrosarcoma can develop from mesenchymal cells and is formed of uncontrollably proliferating spindle-shaped fibroblasts. Most often, fibrosarcoma can arise in the tendons and fascia of deep tissues, although it can also arise in the medullary canal or periosteum of bones. Additionally, preexisting bone lesions or irradiated tissues may cause subsequent bone fibrosarcoma.
Fibrosarcoma often arises from fascia and tendons of deep tissue, although they can also develop in the medullary canal or periosteum of bones as a primary or secondary tumor. Bone fibrosarcoma can be caused by bone injuries which occurred due to radiation therapy or physical trauma.
The 2-year survival rate for fibrosarcoma is below 70%, and the 5-year survival rate is below 55%.
https://www.ncbi.nlm.nih.gov/books/NBK560759/
Fibrosarcomas are malignant tumours made of fibroblasts with variable collagen synthesis and a “herringbone” structure. Previously, the reported incidence was much higher because many non-mesenchymal and mesenchymal tumors which mimic fibrosarcomas were incorrectly diagnosed as fibrosarcoma.
In recent decades this has changed, so the incidence rate has been dropping steadily. There are two forms of fibrosarcomas: infantile or congenital fibrosarcomas, and adult-type fibrosarcomas. Adult-type fibrosarcomas are extremely malignant, whereas infantile fibrosarcomas rarely metastasise.
Fibrosarcomas are more prevalent in middle-aged and elderly individuals, and they are extremely uncommon in youngsters. Males are slightly more likely to be affected. Some common sites which develop fibrosarcoma include deep soft tissues in the head, neck, trunk, and within the pelvic region.
In an analysis of adult fibrosarcomas, 80% were categorized within grades 2 and 3 (high-grade). Out of the lesions which were diagnosed as grade 1, 25% later progressed into high-grade sarcomas over time.
Fibrosarcoma can develop from mesenchymal cells and is formed of uncontrollably proliferating spindle-shaped fibroblasts. Most often, fibrosarcoma can arise in the tendons and fascia of deep tissues, although it can also arise in the medullary canal or periosteum of bones. Additionally, preexisting bone lesions or irradiated tissues may cause subsequent bone fibrosarcoma.
Fibrosarcoma often arises from fascia and tendons of deep tissue, although they can also develop in the medullary canal or periosteum of bones as a primary or secondary tumor. Bone fibrosarcoma can be caused by bone injuries which occurred due to radiation therapy or physical trauma.
The 2-year survival rate for fibrosarcoma is below 70%, and the 5-year survival rate is below 55%.
https://www.ncbi.nlm.nih.gov/books/NBK560759/
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.